Granahan Investment Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Granahan Investment Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,064	Closed	-$22K	–	211
2021 Q1	$22K	Sell	10,064 -75,590	-88%	-$215K	﹤0.01%	191
2020 Q4	$212K	Buy	+85,654	New	+$168K	﹤0.01%	192
2020 Q3	–	Sell	-114,829	Closed	-$340K	–	209
2020 Q2	$340K	Sell	114,829 -39,829	-26%	-$109K	0.01%	187
2020 Q1	$409K	Sell	154,658 -2,286	-1%	-$10.3K	0.02%	176
2019 Q4	$780K	Buy	156,944 +15,932	+11%	+$86.2K	0.04%	163
2019 Q3	$840K	Buy	141,012 +2,471	+2%	+$16.6K	0.05%	161
2019 Q2	$894K	Sell	138,541 -6,042	-4%	-$38.8K	0.04%	166
2019 Q1	$977K	Sell	144,583 -1,261	-0.9%	-$7.55K	0.05%	171
2018 Q4	$594K	Buy	+145,844	New	+$961K	0.04%	175

Other funds holding ETTX

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Granahan Investment Management's ETTX Position: Q2 2021 in Review

Granahan Investment Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2021, closing a stake of 10,064 shares — an estimated $22K sold.

Granahan Investment Management first reported a position in ETTX in Q4 2018 and held it in 9 quarters. The position peaked at $977K in Q1 2019. 24 funds tracked by Wall St. Rank hold ETTX as of Q2 2021.

Granahan Investment Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2021 after selling out during the quarter.
Granahan Investment Management sold 10,064 Entasis Therapeutics Holdings Inc. shares in Q2 2021, an estimated $22K.
Granahan Investment Management first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2018 and held it in 9 quarters.
Granahan Investment Management's Entasis Therapeutics Holdings Inc. position peaked at $977K in Q1 2019.
24 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2021.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.